• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国肾移植术后的早期肾功能不全和晚期静脉血栓栓塞

Early renal insufficiency and late venous thromboembolism after renal transplantation in the United States.

作者信息

Abbott Kevin C, Cruess David F, Agodoa Lawrence Y C, Sawyers Eric S, Tveit Daniel P

机构信息

Nephrology Service, Walter Reed Army Medical Center, Washington, DC 20307-5001, USA.

出版信息

Am J Kidney Dis. 2004 Jan;43(1):120-30. doi: 10.1053/j.ajkd.2003.08.047.

DOI:10.1053/j.ajkd.2003.08.047
PMID:14712435
Abstract

BACKGROUND

Pulmonary embolism (PE) is the most common preventable cause of death in hospitalized patients. Patients with severe chronic kidney disease (CKD) may be at increased risk for PE in comparison to the general population. Whether severe CKD is associated with increased risk for late venous thromboembolism (VTE) in a population of renal transplant recipients has not been determined.

METHODS

Using the US Renal Data System database, we studied 28,924 patients receiving a kidney transplant from January 1, 1996, to July 31, 2000, with Medicare as primary payer, followed up until December 31, 2000. Cox proportional hazards regression models were used to calculate the association of transplant recipient estimated glomerular filtration rate (eGFR; by the Modification of Diet in Renal Disease formula) less than 30 mL/min/1.73 m2 (versus >30 mL/min/1.73 m2) 1 year after renal transplantation with Medicare claims for VTE (either deep-venous thrombosis or PE/infarction) 1.5 to 3 years after renal transplantation.

RESULTS

The rate of VTE occurring 1.5 to 3 years after transplantation was 2.9 episodes/1,000 person-years. eGFR less than 30 mL/min/1.73 m2 versus higher at the end of the first year after renal transplantation was associated with significantly increased risk for later VTE (adjusted hazard ratio, 2.05; 95% confidence interval, 1.08 to 3.89).

CONCLUSION

Patients with severe CKD after renal transplantation should be regarded as high risk for late VTE, which is a potentially preventable cause of death in this population.

摘要

背景

肺栓塞(PE)是住院患者中最常见的可预防死亡原因。与普通人群相比,重度慢性肾脏病(CKD)患者发生PE的风险可能更高。在肾移植受者人群中,重度CKD是否与晚期静脉血栓栓塞(VTE)风险增加相关尚未确定。

方法

利用美国肾脏数据系统数据库,我们研究了1996年1月1日至2000年7月31日期间接受肾移植的28924例患者,以医疗保险作为主要支付方,随访至2000年12月31日。采用Cox比例风险回归模型计算肾移植术后1年估计肾小球滤过率(eGFR;采用肾脏病饮食改良公式)低于30 mL/min/1.73 m2(对比>30 mL/min/1.73 m2)与肾移植术后1.5至3年医疗保险索赔的VTE(深静脉血栓形成或PE/梗死)之间的关联。

结果

移植后1.5至3年发生VTE的发生率为2.9次/1000人年。肾移植术后第1年末eGFR低于30 mL/min/1.73 m2与较高水平相比,与后期VTE风险显著增加相关(调整后风险比为2.05;95%置信区间为1.08至3.89)。

结论

肾移植后患有重度CKD的患者应被视为晚期VTE的高危人群,这是该人群中潜在的可预防死亡原因。

相似文献

1
Early renal insufficiency and late venous thromboembolism after renal transplantation in the United States.美国肾移植术后的早期肾功能不全和晚期静脉血栓栓塞
Am J Kidney Dis. 2004 Jan;43(1):120-30. doi: 10.1053/j.ajkd.2003.08.047.
2
Early renal insufficiency and hospitalized heart disease after renal transplantation in the era of modern immunosuppression.现代免疫抑制时代肾移植后的早期肾功能不全与住院心脏病
J Am Soc Nephrol. 2003 Sep;14(9):2358-65. doi: 10.1097/01.asn.0000083008.25305.67.
3
Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease.静脉血栓栓塞症伴或不伴慢性肾脏病患者结局的评估。
JAMA Netw Open. 2020 Oct 1;3(10):e2022886. doi: 10.1001/jamanetworkopen.2020.22886.
4
Risk factors for hospitalizations resulting from pulmonary embolism after renal transplantation in the United States.美国肾移植后因肺栓塞导致住院的危险因素。
J Nephrol. 2001 Sep-Oct;14(5):361-8.
5
Venous Thromboembolism and the Risk of Death and Graft Loss in Kidney Transplant Recipients.静脉血栓栓塞与肾移植受者的死亡和移植物丢失风险。
Am J Nephrol. 2017;46(4):343-354. doi: 10.1159/000480304. Epub 2017 Oct 12.
6
Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.3期慢性肾脏病患者的估计肾小球滤过率变异性与终末期肾病风险
Clin Nephrol. 2013 Oct;80(4):256-62. doi: 10.5414/CN107905.
7
Risk of venous thromboembolism among hospitalized medically ill patients.内科住院患者发生静脉血栓栓塞症的风险。
Am J Health Syst Pharm. 2006 Oct 15;63(20 Suppl 6):S16-22. doi: 10.2146/ajhp060389.
8
Frequency and predictors of venous thromboembolism in orthotopic liver transplant recipients: a single-center retrospective review.原位肝移植受者静脉血栓栓塞的发生率及预测因素:一项单中心回顾性研究
Transplant Proc. 2013 Jan-Feb;45(1):315-9. doi: 10.1016/j.transproceed.2012.06.060. Epub 2012 Sep 19.
9
Lack of association between airflow limitation and recurrence of venous thromboembolism among cancer patients with pulmonary embolism.患有肺栓塞的癌症患者中气流受限与静脉血栓栓塞复发之间无关联。
Int J Chron Obstruct Pulmon Dis. 2018 Mar 20;13:937-943. doi: 10.2147/COPD.S156130. eCollection 2018.
10
Chronic kidney disease is associated with increased risk of venous thromboembolism recurrence.慢性肾脏病与静脉血栓栓塞复发风险增加相关。
Thromb Res. 2017 Dec;160:32-37. doi: 10.1016/j.thromres.2017.10.011. Epub 2017 Oct 16.

引用本文的文献

1
Developing a genetic testing panel for evaluation of morbidities in kidney transplant recipients.为评估肾移植受者的并发症开发基因检测面板。
Kidney Int. 2024 Jul;106(1):115-125. doi: 10.1016/j.kint.2024.02.021. Epub 2024 Mar 21.
2
Incidence and risk factors of venous thromboembolism in kidney transplantation patients: a prospective cohort study.肾移植患者静脉血栓栓塞的发生率及危险因素:一项前瞻性队列研究。
J Thromb Thrombolysis. 2024 Feb;57(2):278-284. doi: 10.1007/s11239-023-02911-w. Epub 2023 Nov 28.
3
Risk and factors associated with venous thromboembolism following abdominal transplantation.
腹部移植术后静脉血栓栓塞的相关风险及因素
Surg Open Sci. 2023 Mar 30;13:18-23. doi: 10.1016/j.sopen.2023.03.006. eCollection 2023 Jun.
4
The epidemiology of early deep vein thrombosis in kidney transplant recipients.肾移植受者早期深静脉血栓形成的流行病学。
Can J Surg. 2023 Mar 31;66(2):E162-E169. doi: 10.1503/cjs.021821. Print 2023 Mar-Apr.
5
Prevalence, risk, and outcomes of venous thromboembolic events in kidney transplant recipients: a nested case-control study.肾移植受者静脉血栓栓塞事件的流行率、风险和结局:一项巢式病例对照研究。
Ren Fail. 2023 Dec;45(1):2161395. doi: 10.1080/0886022X.2022.2161395.
6
Venous Thromboembolism in Kidney Diseases and Genetic Predisposition.肾脏疾病中的静脉血栓栓塞与遗传易感性
Kidney Dis (Basel). 2022 Apr 11;8(3):181-189. doi: 10.1159/000523777. eCollection 2022 May.
7
Comparative efficacy and safety of oral anticoagulants for the treatment of venous thromboembolism in the patients with different renal functions: a systematic review, pairwise and network meta-analysis.不同肾功能患者口服抗凝药物治疗静脉血栓栓塞症的疗效和安全性比较:系统评价、成对比较和网络荟萃分析。
BMJ Open. 2022 Feb 21;12(2):e048619. doi: 10.1136/bmjopen-2021-048619.
8
Outcome of Elderly Patients with Venous Thromboembolism Treated with Direct Oral Anticoagulants-A Retrospective Cohort Study.直接口服抗凝剂治疗老年静脉血栓栓塞症患者的结局——一项回顾性队列研究
J Clin Med. 2021 Dec 1;10(23):5673. doi: 10.3390/jcm10235673.
9
Increased risk of deep vein thrombosis in end-stage renal disease patients.终末期肾病患者深静脉血栓形成风险增加。
BMC Nephrol. 2018 Aug 16;19(1):204. doi: 10.1186/s12882-018-0989-z.
10
Prophylaxis of Pulmonary Embolism in Kidney Transplant Recipients.肾移植受者肺栓塞的预防。
Curr Urol Rep. 2018 Feb 23;19(2):17. doi: 10.1007/s11934-018-0759-2.